The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Dr. Langer Discusses Remaining Challenges With the Non-Driver NSCLC Population

Corey J. Langer, MD
Published Online: Sep 12,2017

Corey J. Langer, MD, Perelman Center for Advanced Medicine; Hospital of the University of Pennsylvania, discusses remaining challenges in the treatment of patients with non-driver non-small cell lung cancer (NSCLC).


Clinical Articles

Dr. Langer Discusses Remaining Challenges With the Non-Driver NSCLC Population
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.